The Art and Science of Genetic Modification: Re-Engineering Patent Law and Constitutional Orthodoxies.
- Published in:
- Indiana Journal of Global Legal Studies, 2004, v. 11, n. 1, p. 1, doi. 10.2979/GLS.2004.11.1.1
- By:
- Publication type:
- Article
Works matching DE "MYRIAD Genetics Inc."
Results: 120
1
2
News In Brief.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 3, p. 277, doi. 10.1038/nbt0305-277
- Publication type:
- Article
3
People.
- Published in:
- 2004
- Publication type:
- Other
4
Effort to map human proteome.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 5, p. 399, doi. 10.1038/88025
- By:
- Publication type:
- Article
5
Value of rice genome still in the husk.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 3, p. 189, doi. 10.1038/85570
- By:
- Publication type:
- Article
6
RACE TO THE CURE: WHY GENE PATENTS PAVE THE WAY FOR BREAST CANCER RESEARCH.
- Published in:
- American University Journal of Gender, Social Policy & the Law, 2011, v. 19, n. 3, p. 1009
- By:
- Publication type:
- Article
7
Genetic testing goes DTC.
- Published in:
- Marketing Health Services, 2002, v. 22, n. 3, p. 9
- Publication type:
- Article
8
The phantom menace of gene patents.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
9
Genetic patent singles out Jewish women.
- Published in:
- Nature, 2005, v. 436, n. 7047, p. 12, doi. 10.1038/436012a
- By:
- Publication type:
- Article
10
Clinicians win fight to overturn patent for breast-cancer gene.
- Published in:
- Nature, 2004, v. 429, n. 6990, p. 329, doi. 10.1038/429329a
- By:
- Publication type:
- Article
11
Patent Eligible Medical and Biotechnology Inventions After Bilski, Prometheus, and Myriad.
- Published in:
- Texas Intellectual Property Law Journal, 2011, v. 19, n. 3, p. 393
- By:
- Publication type:
- Article
12
What the Supreme Court's Myriad Decision Means for Nanotechnology Patents.
- Published in:
- Nanotechnology Law & Business, 2013, v. 10, p. 132
- By:
- Publication type:
- Article
13
The Patent Eligibility of Graphene Claims Following the U.S. Supreme Court's Myriad Decision.
- Published in:
- Nanotechnology Law & Business, 2013, v. 10, p. 123
- By:
- Publication type:
- Article
14
Taking Nature Back: Why Tax Strategy Law Is Relevant to Gene Patents.
- Published in:
- Missouri Law Review, 2012, v. 77, n. 3, p. 879
- By:
- Publication type:
- Article
15
Staking a Claim on the Building Blocks of Life: Human Genetic Material Within the United States Patent System.
- Published in:
- Missouri Law Review, 2010, v. 75, n. 2, p. 617
- By:
- Publication type:
- Article
16
SHOULD THE NEW ZEALAND PARLIAMENT ALLOW THE INTELLECTUAL PROPERTY OFFICE OF NEW ZEALAND TO CONTINUE TO GRANT PATENTS FOR ISOLATED HUMAN GENES?
- Published in:
- Victoria University of Wellington Law Review, 2013, v. 44, n. 1, p. 91
- By:
- Publication type:
- Article
17
Testing times.
- Published in:
- Nature Genetics, 2012, v. 44, n. 5, p. 473, doi. 10.1038/ng.2264
- Publication type:
- Article
18
The science of spin.
- Published in:
- Medical Laboratory Observer (MLO), 2010, v. 42, n. 8, p. 4
- By:
- Publication type:
- Article
19
New tests.
- Published in:
- Medical Laboratory Observer (MLO), 2001, v. 33, n. 11, p. 6
- Publication type:
- Article
20
In brief.
- Published in:
- Medical Laboratory Observer (MLO), 2000, v. 32, n. 7, p. 12
- Publication type:
- Article
21
WEB WATCH: Networking with proteins.
- Published in:
- Nature Reviews Molecular Cell Biology, 2000, v. 1, n. 1, p. 4, doi. 10.1038/35036005
- By:
- Publication type:
- Article
22
Myriad Further Limits Patent Eligibility.
- Published in:
- BioProcessing Journal, 2013, v. 12, n. 2, p. 37, doi. 10.12665/J122.Merkel
- By:
- Publication type:
- Article
23
Commentary regarding decision in Myriad Genetics on ‘isolated’ DNA claims.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
24
US Financial accounts reports.
- Published in:
- Journal of Commercial Biotechnology, 2002, v. 8, n. 3, p. 262, doi. 10.5912/jcb441
- By:
- Publication type:
- Article
25
CLINICAL TRIALS NEWS.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 11, p. 14
- Publication type:
- Article
26
A "MYRIAD" OF CONTROVERSY OVER THE QUESTION OF HUMAN GENE PATENT ELIGIBILITY: A COMPARISON OF THE DIFFERING APPROACHES IN THE UNITED STATES AND AUSTRALIA.
- Published in:
- Houston Journal of International Law, 2016, v. 38, n. 3, p. 913
- By:
- Publication type:
- Article
27
GENE-PATENTING AND ACCESS TO HEALTHCARE: ACHIEVING PRECISION.
- Published in:
- Houston Journal of International Law, 2014, v. 36, n. 1, p. 101
- By:
- Publication type:
- Article
28
LATEST CLINICAL TRIAL DATA ON DISEASE-MODIFYING THERAPIES FROM THE 2008 INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. 9, p. 24
- By:
- Publication type:
- Article
29
News Updates.
- Published in:
- Brown University Psychopharmacology Update, 2003, v. 14, n. 3, p. 7
- Publication type:
- Article
30
Patents and public health.
- Published in:
- EMBO Reports, 2002, v. 3, n. 12, p. 1120, doi. 10.1093/embo-reports/kvf251
- By:
- Publication type:
- Article
31
THE NEXT STEP IN GENE PATENTS: ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS.
- Published in:
- DePaul Journal of Art, Technology & Intellectual Property Law, 2014, v. 24, n. 2, p. 403
- By:
- Publication type:
- Article
32
WHEN MYRIAD GENETICS PROHIBITED A MYRIAD OF OPTIONS: ASSOCIATION FOR MOLECULAR PATHOLOGY V. USPTO.
- Published in:
- DePaul Journal of Art, Technology & Intellectual Property Law, 2011, v. 21, n. 2, p. 357
- By:
- Publication type:
- Article
33
Cancer gene patent dispute settled.
- Published in:
- JAMA: Journal of the American Medical Association, 1995, v. 273, n. 11, p. 833, doi. 10.1001/jama.1995.03520350015005
- By:
- Publication type:
- Article
34
Patent protection for isolated genes in Australia.
- Published in:
- Journal of Intellectual Property Law & Practice, 2015, v. 10, n. 3, p. 148, doi. 10.1093/jiplp/jpu242
- By:
- Publication type:
- Article
35
US Supreme Court addresses patent eligibility of isolated DNA and cDNA in Myriad V.
- Published in:
- Journal of Intellectual Property Law & Practice, 2013, v. 8, n. 11, p. 811, doi. 10.1093/jiplp/jpt156
- By:
- Publication type:
- Article
36
Fireworks and pharmaceuticals.
- Published in:
- 2014
- Publication type:
- Opinion
37
Gene patents disallowed.
- Published in:
- Chemistry & Industry, 2013, v. 77, n. 7, p. 7
- By:
- Publication type:
- Article
38
THE DISPARATE EFFECTS OF GENE PATENTS ON DIFFERENT CATEGORIES OF SCIENTIFIC RESEARCH.
- Published in:
- Harvard Journal of Law & Technology, 2011, v. 25, n. 1, p. 179
- By:
- Publication type:
- Article
39
Myriad Choices: University Patents Under the Sun.
- Published in:
- Journal of Law & Education, 2013, v. 42, n. 2, p. 313
- By:
- Publication type:
- Article
40
Patent watch: Australian court upholds Myriad's gene patent.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 11, p. 805, doi. 10.1038/nrd4481
- By:
- Publication type:
- Article
41
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 742, doi. 10.1038/nrd3866
- By:
- Publication type:
- Article
42
Novel commercially available genomic tests for prostate cancer: a roadmap to understanding their clinical impact.
- Published in:
- BJU International, 2014, v. 114, n. 3, p. 320, doi. 10.1111/bju.12695
- By:
- Publication type:
- Article
43
Supreme Court Rules Against Gene Patents.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 4, p. 357, doi. 10.1001/jama.2013.8627
- By:
- Publication type:
- Article
44
Are Human Genes Patentable?
- Published in:
- 2013
- By:
- Publication type:
- Opinion
45
ISOLATING THE PATENTABILITY OF GENETIC MATERIALS: THE D'ARCY V MYRIAD GENETICS SAGA.
- Published in:
- Macquarie Law Journal, 2015, v. 15, p. 105
- By:
- Publication type:
- Article
46
ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC: WHAT ARE THE EFFECTS ON CLONING EXTINCT ANIMALS AND AGRICULTURE NOW THAT CDNA IS PATENTABLE?
- Published in:
- Drake Journal of Agricultural Law, 2014, v. 19, n. 3, p. 347
- By:
- Publication type:
- Article
47
NIH researchers receive cut-price BRCA test.
- Published in:
- Nature Medicine, 2000, v. 6, n. 6, p. 610, doi. 10.1038/76149
- By:
- Publication type:
- Article
48
US Appeals Court says genes are patentable, because they are 'separate' from DNA.
- Published in:
- Journal of Intellectual Property Rights, 2011, v. 16, n. 5, p. 439
- Publication type:
- Article
49
Patenting race: The problems of ethnic genetic testing patents.
- Published in:
- Journal of Intellectual Property Rights, 2007, v. 12, n. 3, p. 359
- Publication type:
- Article
50
Concern over BRCA2 patent.
- Published in:
- 2005
- Publication type:
- Excerpt